Allied Scientific Products

SYNthesis Bioventures, located in Parkville, Victoria, is a registered ESVCLP fund specializing in early-stage therapeutics. Their focus is on investing in innovative projects from discovery through preclinical proof of concept, targeting small molecule therapeutics, biologics, and cell and gene therapies that address significant unmet medical needs. The organization is committed to enhancing the continuity of capital from Australian academia to venture financing and capital markets, actively managing portfolio companies and integrating them into their existing operations. With a team of experienced professionals, SYNthesis Bioventures collaborates with leading research institutes to expedite the development of promising therapeutic solutions. Generated from the website